UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model

British journal of pharmacology, 2013-06, Vol.169 (3), p.567-579

2013

Volltextzugriff (PDF)

Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse

PloS one, 2017-12, Vol.12 (12), p.e0184876

2017

Volltextzugriff (PDF)

Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction

Annals of the New York Academy of Sciences, 2008-10, Vol.1141 (1), p.221-232

Carroll, F Ivy

2008

Volltextzugriff (PDF)

Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats

The Journal of pharmacology and experimental therapeutics, 2018-05, Vol.365 (2), p.346-353

2018

Volltextzugriff (PDF)

Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice

Journal of psychopharmacology (Oxford), 2022-11, Vol.36 (11), p.1280-1293

2022

Volltextzugriff (PDF)

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

Psychopharmacologia, 2005-11, Vol.183 (1), p.118-126

2005

Volltextzugriff (PDF)

In vivo pharmacological interactions between a type II positive allosteric modulator of [alpha]7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model

British journal of pharmacology, 2013-06, Vol.169 (3), p.567

2013

Volltextzugriff (PDF)

Effects of Monoamine Reuptake Inhibitors in Assays of Acute Pain-Stimulated and Pain-Depressed Behavior in Rats

The journal of pain, 2013-03, Vol.14 (3), p.246-259

2013

Volltextzugriff (PDF)

Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse

Psychopharmacology, 2010-06, Vol.210 (2), p.285-294

2010

Volltextzugriff (PDF)

The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence

Vaccine, 2015-11, Vol.33 (46), p.6332-6339

2015

Volltextzugriff (PDF)

2002 Medicinal Chemistry Division Award Address: Monoamine Transporters and Opioid Receptors. Targets for Addiction Therapy

Journal of medicinal chemistry, 2003-05, Vol.46 (10), p.1775-1794

Carroll, F. Ivy

2003

Volltextzugriff (PDF)

Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities

Biochemical pharmacology, 2012-02, Vol.83 (4), p.543-550

2012

Volltextzugriff (PDF)

Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors

Molecular pharmacology, 2004-09, Vol.66 (3), p.675-682

2004

Volltextzugriff (PDF)

Epibatidine structure–activity relationships

Bioorganic & medicinal chemistry letters, 2004-04, Vol.14 (8), p.1889-1896

Carroll, F.Ivy

2004

Volltextzugriff (PDF)

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors

The Journal of neuroscience, 2003-11, Vol.23 (32), p.10331-10337

2003

Volltextzugriff (PDF)

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Synapse (New York, N.Y.), 2001-01, Vol.39 (1), p.32-41

2001

Volltextzugriff (PDF)

Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical Aspects

Journal of medicinal chemistry, 1999-07, Vol.42 (15), p.2721-2736

1999

Volltextzugriff (PDF)

Opioids and addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes

Clinical neuroscience research, 2005-11, Vol.5 (2), p.103-115

2005

Volltextzugriff (PDF)

Neutral antagonist activity of naltrexone and 6β‐naltrexol in naïve and opioid‐dependent C6 cells expressing a µ‐opioid receptor

British journal of pharmacology, 2009-04, Vol.156 (7), p.1044-1053

2009

Volltextzugriff (PDF)

Concurrent Autoreceptor-Mediated Control of Dopamine Release and Uptake during Neurotransmission: An In Vivo Voltammetric Study

The Journal of neuroscience, 2002-07, Vol.22 (14), p.6272-6281

2002

Volltextzugriff (PDF)

An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine

Journal of psychopharmacology (Oxford), 2010-06, Vol.24 (6), p.817-828

2010

Volltextzugriff (PDF)

Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)

ACS chemical neuroscience, 2015-12, Vol.6 (12), p.1956-1964

2015

Volltextzugriff (PDF)

A reduced rate of in Vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants

Neuropsychopharmacology (New York, N.Y.), 2006-02, Vol.31 (2), p.351-362

2006

Volltextzugriff (PDF)

Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys

Pharmacology, biochemistry and behavior, 2007-01, Vol.86 (1), p.45-54

2007

Volltextzugriff (PDF)

Tritiation of SR141716 by metallation-iodination-reduction: tritium-proton nOe study

Journal of labelled compounds & radiopharmaceuticals, 2002-01, Vol.45 (1), p.59-70

2002

Volltextzugriff (PDF)

1 – 25 von 293

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(263)

Publikationsform

Artikel
(291)
Reviews
(2)

Sprache

Englisch
(293)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(279)
Life Sciences & Biomedicine
(215)
Animals
(162)
Pharmacology & Pharmacy
(151)
Male
(101)
Rats
(101)
Chemistry
(100)
Chemistry, Medicinal
(93)
Biological And Medical Sciences
(91)
Physical Sciences
(83)
Medical Sciences
(78)
Cocaine - Analogs & Derivatives
(68)
Neurosciences
(63)
Neurosciences & Neurology
(63)
Dopamine Plasma Membrane Transport Proteins
(54)
Pharmacology. Drug Treatments
(53)
Chemistry, Organic
(52)
Mice
(52)
Membrane Transport Proteins
(50)
Nerve Tissue Proteins
(50)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model

Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse

Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction

Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats

Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

In vivo pharmacological interactions between a type II positive allosteric modulator of [alpha]7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model

Effects of Monoamine Reuptake Inhibitors in Assays of Acute Pain-Stimulated and Pain-Depressed Behavior in Rats

Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse

The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence

2002 Medicinal Chemistry Division Award Address: Monoamine Transporters and Opioid Receptors. Targets for Addiction Therapy

Structurally distinct nicotine immunogens elicit antibodies with non-overlapping specificities

Enantioselective Effects of Hydroxy Metabolites of Bupropion on Behavior and on Function of Monoamine Transporters and Nicotinic Receptors

Epibatidine structure–activity relationships

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical Aspects

Opioids and addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes

Neutral antagonist activity of naltrexone and 6β‐naltrexol in naïve and opioid‐dependent C6 cells expressing a µ‐opioid receptor

Concurrent Autoreceptor-Mediated Control of Dopamine Release and Uptake during Neurotransmission: An In Vivo Voltammetric Study

An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine

Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)

A reduced rate of in Vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants

Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys

Tritiation of SR141716 by metallation-iodination-reduction: tritium-proton nOe study

Suchergebnisse filtern